Industry Research Reports
Global Competent Cells Market Insights, Forecast to 2030
Industry: Medical Care
Published Date: 2024-04-07
Pages: 127 Pages
Report ld: 2709026
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Competent Cells Market Size(US$)
CAGR 2024-2030
9.5%
Market Size,2030
USD 3,782
Million
Market Snapshot
Market Size in 2024 (Value)
US$ 2,194 million
Market Forecast in 2030(Value)
US$ 3,782 million
CAGR
9.5%
Years Considered
2019-2030
Base Year
2024
Forecast Period
2024-2030
Source: Secondary research, interviews with experts, and QYResearch analysis
Competent cells are bacteria which can accept extra-chromosomal DNA or plasmids. Cells can be made competent in several ways. One such way is to "shock" it, which involves cooling the bacteria in a Calcium Chloride bath at 0 degrees Celsius, then quickly heating it to around 47 degrees Celsius for approximately 90 seconds (too long will denature the cell membrane, killing the bacteria). The calcium chloride ions neutralize the repulsion between the negatively charged phospholipid heads of the cell membrane and the negatively charged phosphate groups on the DNA. The quick heat shock creates a thermal gradient which, in turn, creates a draft leading into the cell, allowing extra-chromosomal DNA (such as plasmids) to enter the cell, allowing the bacterium to be genetically modifed.
Market Analysis and Insights: Global Competent Cells Market
The global Competent Cells market is projected to grow from US$ 2194 million in 2024 to US$ 3782 million by 2030, at a Compound Annual Growth Rate (CAGR) of 9.5% during the forecast period.
Global Competent Cells key players include Beijing TransGen Biotech, Merck KGaA, Thermo Fisher Scientific, Agilent Technologies, etc. Global top four manufacturers hold a share nearly 30%.
North America is the largest market, with a share about 10%, followed by Asia-Pacific and Europe, both have a share about 20 percent.
In terms of product, Chemically Competent Cells is the largest segment, with a share nearly 65%. And in terms of application, the largest application is Protein Expression, followed by Subcloning & Routine Cloning, Phage Display Library Construction, Toxic/Unstable DNA Cloning, etc.
Report Covers:
This report presents an overview of global market for Competent Cells market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Competent Cells, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Competent Cells, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Competent Cells revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Competent Cells market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Competent Cells revenue, projected growth trends, production technology, application and end-user industry.
MARKET SEGMENTATION
By Company
- Merck KGaA
- Thermo Fisher Scientific
- Agilent Technologies
- Takara Bio
- Promega Corporation
- Beijing TransGen Biotech
- GeneScript Corporation
- Yeastern Biotech
- New England Biolabs
- QIAGEN N.V.
- OriGene Technologies
- Lucigen
- Zymo Research
- Bio-Rad Laboratories
- Bioline
- Delphi Genetics
- IBA GmBH
- Cell Applications
- BioDynamics Laboratory
- Scarab Genomics
- GCC Biotech
- SMOBIO Technology
- Edge BioSystems
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Chemically Competent Cells
- Electrocompetent Cells
Segment by Application
- Subcloning & Routine Cloning
- Phage Display Library Construction
- Toxic/Unstable DNA Cloning
- High-Throughput Cloning
- Protein Expression
- Mutagenesis
- Single-Stranded DNA Production
- Bacmid Creation
- Cre-Lox Recombination (PIR1/PIR2)
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Competent Cells Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Chemically Competent Cells
1.2.3 Electrocompetent Cells
1.3 Market by Application
1.3.1 Global Competent Cells Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Subcloning & Routine Cloning
1.3.3 Phage Display Library Construction
1.3.4 Toxic/Unstable DNA Cloning
1.3.5 High-Throughput Cloning
1.3.6 Protein Expression
1.3.7 Mutagenesis
1.3.8 Single-Stranded DNA Production
1.3.9 Bacmid Creation
1.3.10 Cre-Lox Recombination (PIR1/PIR2)
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Competent Cells Market Perspective (2019-2030)
2.2 Global Competent Cells Growth Trends by Region
2.2.1 Competent Cells Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Competent Cells Historic Market Size by Region (2019-2024)
2.2.3 Competent Cells Forecasted Market Size by Region (2025-2030)
2.3 Competent Cells Market Dynamics
2.3.1 Competent Cells Industry Trends
2.3.2 Competent Cells Market Drivers
2.3.3 Competent Cells Market Challenges
2.3.4 Competent Cells Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Competent Cells by Players
3.1.1 Global Competent Cells Revenue by Players (2019-2024)
3.1.2 Global Competent Cells Revenue Market Share by Players (2019-2024)
3.2 Global Competent Cells Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Competent Cells, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Competent Cells Market Concentration Ratio
3.4.1 Global Competent Cells Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Competent Cells Revenue in 2023
3.5 Global Key Players of Competent Cells Head office and Area Served
3.6 Global Key Players of Competent Cells, Product and Application
3.7 Global Key Players of Competent Cells, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Competent Cells Breakdown Data by Type
4.1 Global Competent Cells Historic Market Size by Type (2019-2024)
4.2 Global Competent Cells Forecasted Market Size by Type (2025-2030)
5 Competent Cells Breakdown Data by Application
5.1 Global Competent Cells Historic Market Size by Application (2019-2024)
5.2 Global Competent Cells Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Competent Cells Market Size (2019-2030)
6.2 North America Competent Cells Market Size by Type
6.2.1 North America Competent Cells Market Size by Type (2019-2024)
6.2.2 North America Competent Cells Market Size by Type (2025-2030)
6.2.3 North America Competent Cells Market Share by Type (2019-2030)
6.3 North America Competent Cells Market Size by Application
6.3.1 North America Competent Cells Market Size by Application (2019-2024)
6.3.2 North America Competent Cells Market Size by Application (2025-2030)
6.3.3 North America Competent Cells Market Share by Application (2019-2030)
6.4 North America Competent Cells Market Size by Country
6.4.1 North America Competent Cells Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Competent Cells Market Size by Country (2019-2024)
6.4.3 North America Competent Cells Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Competent Cells Market Size (2019-2030)
7.2 Europe Competent Cells Market Size by Type
7.2.1 Europe Competent Cells Market Size by Type (2019-2024)
7.2.2 Europe Competent Cells Market Size by Type (2025-2030)
7.2.3 Europe Competent Cells Market Share by Type (2019-2030)
7.3 Europe Competent Cells Market Size by Application
7.3.1 Europe Competent Cells Market Size by Application (2019-2024)
7.3.2 Europe Competent Cells Market Size by Application (2025-2030)
7.3.3 Europe Competent Cells Market Share by Application (2019-2030)
7.4 Europe Competent Cells Market Size by Country
7.4.1 Europe Competent Cells Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Competent Cells Market Size by Country (2019-2024)
7.4.3 Europe Competent Cells Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Competent Cells Market Size (2019-2030)
8.2 China Competent Cells Market Size by Type
8.2.1 China Competent Cells Market Size by Type (2019-2024)
8.2.2 China Competent Cells Market Size by Type (2025-2030)
8.2.3 China Competent Cells Market Share by Type (2019-2030)
8.3 China Competent Cells Market Size by Application
8.3.1 China Competent Cells Market Size by Application (2019-2024)
8.3.2 China Competent Cells Market Size by Application (2025-2030)
8.3.3 China Competent Cells Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Competent Cells Market Size (2019-2030)
9.2 Asia Competent Cells Market Size by Type
9.2.1 Asia Competent Cells Market Size by Type (2019-2024)
9.2.2 Asia Competent Cells Market Size by Type (2025-2030)
9.2.3 Asia Competent Cells Market Share by Type (2019-2030)
9.3 Asia Competent Cells Market Size by Application
9.3.1 Asia Competent Cells Market Size by Application (2019-2024)
9.3.2 Asia Competent Cells Market Size by Application (2025-2030)
9.3.3 Asia Competent Cells Market Share by Application (2019-2030)
9.4 Asia Competent Cells Market Size by Region
9.4.1 Asia Competent Cells Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Competent Cells Market Size by Region (2019-2024)
9.4.3 Asia Competent Cells Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Competent Cells Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Competent Cells Market Size by Type
10.2.1 Middle East, Africa, and Latin America Competent Cells Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Competent Cells Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Competent Cells Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Competent Cells Market Size by Application
10.3.1 Middle East, Africa, and Latin America Competent Cells Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Competent Cells Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Competent Cells Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Competent Cells Market Size by Country
10.4.1 Middle East, Africa, and Latin America Competent Cells Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Competent Cells Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Competent Cells Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Merck KGaA
11.1.1 Merck KGaA Company Details
11.1.2 Merck KGaA Business Overview
11.1.3 Merck KGaA Competent Cells Introduction
11.1.4 Merck KGaA Revenue in Competent Cells Business (2019-2024)
11.1.5 Merck KGaA Recent Developments
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Details
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Competent Cells Introduction
11.2.4 Thermo Fisher Scientific Revenue in Competent Cells Business (2019-2024)
11.2.5 Thermo Fisher Scientific Recent Developments
11.3 Agilent Technologies
11.3.1 Agilent Technologies Company Details
11.3.2 Agilent Technologies Business Overview
11.3.3 Agilent Technologies Competent Cells Introduction
11.3.4 Agilent Technologies Revenue in Competent Cells Business (2019-2024)
11.3.5 Agilent Technologies Recent Developments
11.4 Takara Bio
11.4.1 Takara Bio Company Details
11.4.2 Takara Bio Business Overview
11.4.3 Takara Bio Competent Cells Introduction
11.4.4 Takara Bio Revenue in Competent Cells Business (2019-2024)
11.4.5 Takara Bio Recent Developments
11.5 Promega Corporation
11.5.1 Promega Corporation Company Details
11.5.2 Promega Corporation Business Overview
11.5.3 Promega Corporation Competent Cells Introduction
11.5.4 Promega Corporation Revenue in Competent Cells Business (2019-2024)
11.5.5 Promega Corporation Recent Developments
11.6 Beijing TransGen Biotech
11.6.1 Beijing TransGen Biotech Company Details
11.6.2 Beijing TransGen Biotech Business Overview
11.6.3 Beijing TransGen Biotech Competent Cells Introduction
11.6.4 Beijing TransGen Biotech Revenue in Competent Cells Business (2019-2024)
11.6.5 Beijing TransGen Biotech Recent Developments
11.7 GeneScript Corporation
11.7.1 GeneScript Corporation Company Details
11.7.2 GeneScript Corporation Business Overview
11.7.3 GeneScript Corporation Competent Cells Introduction
11.7.4 GeneScript Corporation Revenue in Competent Cells Business (2019-2024)
11.7.5 GeneScript Corporation Recent Developments
11.8 Yeastern Biotech
11.8.1 Yeastern Biotech Company Details
11.8.2 Yeastern Biotech Business Overview
11.8.3 Yeastern Biotech Competent Cells Introduction
11.8.4 Yeastern Biotech Revenue in Competent Cells Business (2019-2024)
11.8.5 Yeastern Biotech Recent Developments
11.9 New England Biolabs
11.9.1 New England Biolabs Company Details
11.9.2 New England Biolabs Business Overview
11.9.3 New England Biolabs Competent Cells Introduction
11.9.4 New England Biolabs Revenue in Competent Cells Business (2019-2024)
11.9.5 New England Biolabs Recent Developments
11.10 QIAGEN N.V.
11.10.1 QIAGEN N.V. Company Details
11.10.2 QIAGEN N.V. Business Overview
11.10.3 QIAGEN N.V. Competent Cells Introduction
11.10.4 QIAGEN N.V. Revenue in Competent Cells Business (2019-2024)
11.10.5 QIAGEN N.V. Recent Developments
11.11 OriGene Technologies
11.11.1 OriGene Technologies Company Details
11.11.2 OriGene Technologies Business Overview
11.11.3 OriGene Technologies Competent Cells Introduction
11.11.4 OriGene Technologies Revenue in Competent Cells Business (2019-2024)
11.11.5 OriGene Technologies Recent Developments
11.12 Lucigen
11.12.1 Lucigen Company Details
11.12.2 Lucigen Business Overview
11.12.3 Lucigen Competent Cells Introduction
11.12.4 Lucigen Revenue in Competent Cells Business (2019-2024)
11.12.5 Lucigen Recent Developments
11.13 Zymo Research
11.13.1 Zymo Research Company Details
11.13.2 Zymo Research Business Overview
11.13.3 Zymo Research Competent Cells Introduction
11.13.4 Zymo Research Revenue in Competent Cells Business (2019-2024)
11.13.5 Zymo Research Recent Developments
11.14 Bio-Rad Laboratories
11.14.1 Bio-Rad Laboratories Company Details
11.14.2 Bio-Rad Laboratories Business Overview
11.14.3 Bio-Rad Laboratories Competent Cells Introduction
11.14.4 Bio-Rad Laboratories Revenue in Competent Cells Business (2019-2024)
11.14.5 Bio-Rad Laboratories Recent Developments
11.15 Bioline
11.15.1 Bioline Company Details
11.15.2 Bioline Business Overview
11.15.3 Bioline Competent Cells Introduction
11.15.4 Bioline Revenue in Competent Cells Business (2019-2024)
11.15.5 Bioline Recent Developments
11.16 Delphi Genetics
11.16.1 Delphi Genetics Company Details
11.16.2 Delphi Genetics Business Overview
11.16.3 Delphi Genetics Competent Cells Introduction
11.16.4 Delphi Genetics Revenue in Competent Cells Business (2019-2024)
11.16.5 Delphi Genetics Recent Developments
11.17 IBA GmBH
11.17.1 IBA GmBH Company Details
11.17.2 IBA GmBH Business Overview
11.17.3 IBA GmBH Competent Cells Introduction
11.17.4 IBA GmBH Revenue in Competent Cells Business (2019-2024)
11.17.5 IBA GmBH Recent Developments
11.18 Cell Applications
11.18.1 Cell Applications Company Details
11.18.2 Cell Applications Business Overview
11.18.3 Cell Applications Competent Cells Introduction
11.18.4 Cell Applications Revenue in Competent Cells Business (2019-2024)
11.18.5 Cell Applications Recent Developments
11.19 BioDynamics Laboratory
11.19.1 BioDynamics Laboratory Company Details
11.19.2 BioDynamics Laboratory Business Overview
11.19.3 BioDynamics Laboratory Competent Cells Introduction
11.19.4 BioDynamics Laboratory Revenue in Competent Cells Business (2019-2024)
11.19.5 BioDynamics Laboratory Recent Developments
11.20 Scarab Genomics
11.20.1 Scarab Genomics Company Details
11.20.2 Scarab Genomics Business Overview
11.20.3 Scarab Genomics Competent Cells Introduction
11.20.4 Scarab Genomics Revenue in Competent Cells Business (2019-2024)
11.20.5 Scarab Genomics Recent Developments
11.21 GCC Biotech
11.21.1 GCC Biotech Company Details
11.21.2 GCC Biotech Business Overview
11.21.3 GCC Biotech Competent Cells Introduction
11.21.4 GCC Biotech Revenue in Competent Cells Business (2019-2024)
11.21.5 GCC Biotech Recent Developments
11.22 SMOBIO Technology
11.22.1 SMOBIO Technology Company Details
11.22.2 SMOBIO Technology Business Overview
11.22.3 SMOBIO Technology Competent Cells Introduction
11.22.4 SMOBIO Technology Revenue in Competent Cells Business (2019-2024)
11.22.5 SMOBIO Technology Recent Developments
11.23 Edge BioSystems
11.23.1 Edge BioSystems Company Details
11.23.2 Edge BioSystems Business Overview
11.23.3 Edge BioSystems Competent Cells Introduction
11.23.4 Edge BioSystems Revenue in Competent Cells Business (2019-2024)
11.23.5 Edge BioSystems Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Competent Cells Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 2. Key Players of Chemically Competent Cells
Table 3. Key Players of Electrocompetent Cells
Table 4. Global Competent Cells Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 5. Global Competent Cells Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Competent Cells Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Competent Cells Market Share by Region (2019-2024)
Table 8. Global Competent Cells Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Competent Cells Market Share by Region (2025-2030)
Table 10. Competent Cells Market Trends
Table 11. Competent Cells Market Drivers
Table 12. Competent Cells Market Challenges
Table 13. Competent Cells Market Restraints
Table 14. Global Competent Cells Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Competent Cells Revenue Share by Players (2019-2024)
Table 16. Global Top Competent Cells by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Competent Cells as of 2023)
Table 17. Global Competent Cells Industry Ranking 2022 VS 2023 VS 2024
Table 18. Global 5 Largest Players Market Share by Competent Cells Revenue (CR5 and HHI) & (2019-2024)
Table 19. Global Key Players of Competent Cells, Headquarters and Area Served
Table 20. Global Key Players of Competent Cells, Product and Application
Table 21. Global Key Players of Competent Cells, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Competent Cells Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Competent Cells Revenue Market Share by Type (2019-2024)
Table 25. Global Competent Cells Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Competent Cells Revenue Market Share by Type (2025-2030)
Table 27. Global Competent Cells Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Competent Cells Revenue Share by Application (2019-2024)
Table 29. Global Competent Cells Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Competent Cells Revenue Share by Application (2025-2030)
Table 31. North America Competent Cells Market Size by Type (2019-2024) & (US$ Million)
Table 32. North America Competent Cells Market Size by Type (2025-2030) & (US$ Million)
Table 33. North America Competent Cells Market Size by Application (2019-2024) & (US$ Million)
Table 34. North America Competent Cells Market Size by Application (2025-2030) & (US$ Million)
Table 35. North America Competent Cells Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. North America Competent Cells Market Size by Country (2019-2024) & (US$ Million)
Table 37. North America Competent Cells Market Size by Country (2025-2030) & (US$ Million)
Table 38. Europe Competent Cells Market Size by Type (2019-2024) & (US$ Million)
Table 39. Europe Competent Cells Market Size by Type (2025-2030) & (US$ Million)
Table 40. Europe Competent Cells Market Size by Application (2019-2024) & (US$ Million)
Table 41. Europe Competent Cells Market Size by Application (2025-2030) & (US$ Million)
Table 42. Europe Competent Cells Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Europe Competent Cells Market Size by Country (2019-2024) & (US$ Million)
Table 44. Europe Competent Cells Market Size by Country (2025-2030) & (US$ Million)
Table 45. China Competent Cells Market Size by Type (2019-2024) & (US$ Million)
Table 46. China Competent Cells Market Size by Type (2025-2030) & (US$ Million)
Table 47. China Competent Cells Market Size by Application (2019-2024) & (US$ Million)
Table 48. China Competent Cells Market Size by Application (2025-2030) & (US$ Million)
Table 49. Asia Competent Cells Market Size by Type (2019-2024) & (US$ Million)
Table 50. Asia Competent Cells Market Size by Type (2025-2030) & (US$ Million)
Table 51. Asia Competent Cells Market Size by Application (2019-2024) & (US$ Million)
Table 52. Asia Competent Cells Market Size by Application (2025-2030) & (US$ Million)
Table 53. Asia Competent Cells Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 54. Asia Competent Cells Market Size by Region (2019-2024) & (US$ Million)
Table 55. Asia Competent Cells Market Size by Region (2025-2030) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Competent Cells Market Size by Type (2019-2024) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Competent Cells Market Size by Type (2025-2030) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Competent Cells Market Size by Application (2019-2024) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Competent Cells Market Size by Application (2025-2030) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Competent Cells Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 61. Middle East, Africa, and Latin America Competent Cells Market Size by Country (2019-2024) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Competent Cells Market Size by Country (2025-2030) & (US$ Million)
Table 63. Merck KGaA Company Details
Table 64. Merck KGaA Business Overview
Table 65. Merck KGaA Competent Cells Product
Table 66. Merck KGaA Revenue in Competent Cells Business (2019-2024) & (US$ Million)
Table 67. Merck KGaA Recent Developments
Table 68. Thermo Fisher Scientific Company Details
Table 69. Thermo Fisher Scientific Business Overview
Table 70. Thermo Fisher Scientific Competent Cells Product
Table 71. Thermo Fisher Scientific Revenue in Competent Cells Business (2019-2024) & (US$ Million)
Table 72. Thermo Fisher Scientific Recent Developments
Table 73. Agilent Technologies Company Details
Table 74. Agilent Technologies Business Overview
Table 75. Agilent Technologies Competent Cells Product
Table 76. Agilent Technologies Revenue in Competent Cells Business (2019-2024) & (US$ Million)
Table 77. Agilent Technologies Recent Developments
Table 78. Takara Bio Company Details
Table 79. Takara Bio Business Overview
Table 80. Takara Bio Competent Cells Product
Table 81. Takara Bio Revenue in Competent Cells Business (2019-2024) & (US$ Million)
Table 82. Takara Bio Recent Developments
Table 83. Promega Corporation Company Details
Table 84. Promega Corporation Business Overview
Table 85. Promega Corporation Competent Cells Product
Table 86. Promega Corporation Revenue in Competent Cells Business (2019-2024) & (US$ Million)
Table 87. Promega Corporation Recent Developments
Table 88. Beijing TransGen Biotech Company Details
Table 89. Beijing TransGen Biotech Business Overview
Table 90. Beijing TransGen Biotech Competent Cells Product
Table 91. Beijing TransGen Biotech Revenue in Competent Cells Business (2019-2024) & (US$ Million)
Table 92. Beijing TransGen Biotech Recent Developments
Table 93. GeneScript Corporation Company Details
Table 94. GeneScript Corporation Business Overview
Table 95. GeneScript Corporation Competent Cells Product
Table 96. GeneScript Corporation Revenue in Competent Cells Business (2019-2024) & (US$ Million)
Table 97. GeneScript Corporation Recent Developments
Table 98. Yeastern Biotech Company Details
Table 99. Yeastern Biotech Business Overview
Table 100. Yeastern Biotech Competent Cells Product
Table 101. Yeastern Biotech Revenue in Competent Cells Business (2019-2024) & (US$ Million)
Table 102. Yeastern Biotech Recent Developments
Table 103. New England Biolabs Company Details
Table 104. New England Biolabs Business Overview
Table 105. New England Biolabs Competent Cells Product
Table 106. New England Biolabs Revenue in Competent Cells Business (2019-2024) & (US$ Million)
Table 107. New England Biolabs Recent Developments
Table 108. QIAGEN N.V. Company Details
Table 109. QIAGEN N.V. Business Overview
Table 110. QIAGEN N.V. Competent Cells Product
Table 111. QIAGEN N.V. Revenue in Competent Cells Business (2019-2024) & (US$ Million)
Table 112. QIAGEN N.V. Recent Developments
Table 113. OriGene Technologies Company Details
Table 114. OriGene Technologies Business Overview
Table 115. OriGene Technologies Competent Cells Product
Table 116. OriGene Technologies Revenue in Competent Cells Business (2019-2024) & (US$ Million)
Table 117. OriGene Technologies Recent Developments
Table 118. Lucigen Company Details
Table 119. Lucigen Business Overview
Table 120. Lucigen Competent Cells Product
Table 121. Lucigen Revenue in Competent Cells Business (2019-2024) & (US$ Million)
Table 122. Lucigen Recent Developments
Table 123. Zymo Research Company Details
Table 124. Zymo Research Business Overview
Table 125. Zymo Research Competent Cells Product
Table 126. Zymo Research Revenue in Competent Cells Business (2019-2024) & (US$ Million)
Table 127. Zymo Research Recent Developments
Table 128. Bio-Rad Laboratories Company Details
Table 129. Bio-Rad Laboratories Business Overview
Table 130. Bio-Rad Laboratories Competent Cells Product
Table 131. Bio-Rad Laboratories Revenue in Competent Cells Business (2019-2024) & (US$ Million)
Table 132. Bio-Rad Laboratories Recent Developments
Table 133. Bioline Company Details
Table 134. Bioline Business Overview
Table 135. Bioline Competent Cells Product
Table 136. Bioline Revenue in Competent Cells Business (2019-2024) & (US$ Million)
Table 137. Bioline Recent Developments
Table 138. Delphi Genetics Company Details
Table 139. Delphi Genetics Business Overview
Table 140. Delphi Genetics Competent Cells Product
Table 141. Delphi Genetics Revenue in Competent Cells Business (2019-2024) & (US$ Million)
Table 142. Delphi Genetics Recent Developments
Table 143. IBA GmBH Company Details
Table 144. IBA GmBH Business Overview
Table 145. IBA GmBH Competent Cells Product
Table 146. IBA GmBH Revenue in Competent Cells Business (2019-2024) & (US$ Million)
Table 147. IBA GmBH Recent Developments
Table 148. Cell Applications Company Details
Table 149. Cell Applications Business Overview
Table 150. Cell Applications Competent Cells Product
Table 151. Cell Applications Revenue in Competent Cells Business (2019-2024) & (US$ Million)
Table 152. Cell Applications Recent Developments
Table 153. BioDynamics Laboratory Company Details
Table 154. BioDynamics Laboratory Business Overview
Table 155. BioDynamics Laboratory Competent Cells Product
Table 156. BioDynamics Laboratory Revenue in Competent Cells Business (2019-2024) & (US$ Million)
Table 157. BioDynamics Laboratory Recent Developments
Table 158. Scarab Genomics Company Details
Table 159. Scarab Genomics Business Overview
Table 160. Scarab Genomics Competent Cells Product
Table 161. Scarab Genomics Revenue in Competent Cells Business (2019-2024) & (US$ Million)
Table 162. Scarab Genomics Recent Developments
Table 163. GCC Biotech Company Details
Table 164. GCC Biotech Business Overview
Table 165. GCC Biotech Competent Cells Product
Table 166. GCC Biotech Revenue in Competent Cells Business (2019-2024) & (US$ Million)
Table 167. GCC Biotech Recent Developments
Table 168. SMOBIO Technology Company Details
Table 169. SMOBIO Technology Business Overview
Table 170. SMOBIO Technology Competent Cells Product
Table 171. SMOBIO Technology Revenue in Competent Cells Business (2019-2024) & (US$ Million)
Table 172. SMOBIO Technology Recent Developments
Table 173. Edge BioSystems Company Details
Table 174. Edge BioSystems Business Overview
Table 175. Edge BioSystems Competent Cells Product
Table 176. Edge BioSystems Revenue in Competent Cells Business (2019-2024) & (US$ Million)
Table 177. Edge BioSystems Recent Developments
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Competent Cells Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 2. Global Competent Cells Market Share by Type: 2023 VS 2030
Figure 3. Chemically Competent Cells Features
Figure 4. Electrocompetent Cells Features
Figure 5. Global Competent Cells Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 6. Global Competent Cells Market Share by Application: 2023 VS 2030
Figure 7. Subcloning & Routine Cloning Case Studies
Figure 8. Phage Display Library Construction Case Studies
Figure 9. Toxic/Unstable DNA Cloning Case Studies
Figure 10. High-Throughput Cloning Case Studies
Figure 11. Protein Expression Case Studies
Figure 12. Mutagenesis Case Studies
Figure 13. Single-Stranded DNA Production Case Studies
Figure 14. Bacmid Creation Case Studies
Figure 15. Cre-Lox Recombination (PIR1/PIR2) Case Studies
Figure 16. Competent Cells Report Years Considered
Figure 17. Global Competent Cells Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 18. Global Competent Cells Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 19. Global Competent Cells Market Share by Region: 2023 VS 2030
Figure 20. Global Competent Cells Market Share by Players in 2023
Figure 21. Global Top Competent Cells Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Competent Cells as of 2023)
Figure 22. The Top 10 and 5 Players Market Share by Competent Cells Revenue in 2023
Figure 23. North America Competent Cells Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. North America Competent Cells Market Share by Type (2019-2030)
Figure 25. North America Competent Cells Market Share by Application (2019-2030)
Figure 26. North America Competent Cells Market Share by Country (2019-2030)
Figure 27. United States Competent Cells Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Canada Competent Cells Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Europe Competent Cells Market Size YoY (2019-2030) & (US$ Million)
Figure 30. Europe Competent Cells Market Share by Type (2019-2030)
Figure 31. Europe Competent Cells Market Share by Application (2019-2030)
Figure 32. Europe Competent Cells Market Share by Country (2019-2030)
Figure 33. Germany Competent Cells Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. France Competent Cells Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. U.K. Competent Cells Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Italy Competent Cells Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Russia Competent Cells Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Nordic Countries Competent Cells Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. China Competent Cells Market Size YoY (2019-2030) & (US$ Million)
Figure 40. China Competent Cells Market Share by Type (2019-2030)
Figure 41. China Competent Cells Market Share by Application (2019-2030)
Figure 42. Asia Competent Cells Market Size YoY (2019-2030) & (US$ Million)
Figure 43. Asia Competent Cells Market Share by Type (2019-2030)
Figure 44. Asia Competent Cells Market Share by Application (2019-2030)
Figure 45. Asia Competent Cells Market Share by Region (2019-2030)
Figure 46. Japan Competent Cells Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. South Korea Competent Cells Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. China Taiwan Competent Cells Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Southeast Asia Competent Cells Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. India Competent Cells Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 51. Australia Competent Cells Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 52. Middle East, Africa, and Latin America Competent Cells Market Size YoY (2019-2030) & (US$ Million)
Figure 53. Middle East, Africa, and Latin America Competent Cells Market Share by Type (2019-2030)
Figure 54. Middle East, Africa, and Latin America Competent Cells Market Share by Application (2019-2030)
Figure 55. Middle East, Africa, and Latin America Competent Cells Market Share by Country (2019-2030)
Figure 56. Brazil Competent Cells Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 57. Mexico Competent Cells Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 58. Turkey Competent Cells Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 59. Saudi Arabia Competent Cells Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 60. Israel Competent Cells Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 61. GCC Countries Competent Cells Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 62. Merck KGaA Revenue Growth Rate in Competent Cells Business (2019-2024)
Figure 63. Thermo Fisher Scientific Revenue Growth Rate in Competent Cells Business (2019-2024)
Figure 64. Agilent Technologies Revenue Growth Rate in Competent Cells Business (2019-2024)
Figure 65. Takara Bio Revenue Growth Rate in Competent Cells Business (2019-2024)
Figure 66. Promega Corporation Revenue Growth Rate in Competent Cells Business (2019-2024)
Figure 67. Beijing TransGen Biotech Revenue Growth Rate in Competent Cells Business (2019-2024)
Figure 68. GeneScript Corporation Revenue Growth Rate in Competent Cells Business (2019-2024)
Figure 69. Yeastern Biotech Revenue Growth Rate in Competent Cells Business (2019-2024)
Figure 70. New England Biolabs Revenue Growth Rate in Competent Cells Business (2019-2024)
Figure 71. QIAGEN N.V. Revenue Growth Rate in Competent Cells Business (2019-2024)
Figure 72. OriGene Technologies Revenue Growth Rate in Competent Cells Business (2019-2024)
Figure 73. Lucigen Revenue Growth Rate in Competent Cells Business (2019-2024)
Figure 74. Zymo Research Revenue Growth Rate in Competent Cells Business (2019-2024)
Figure 75. Bio-Rad Laboratories Revenue Growth Rate in Competent Cells Business (2019-2024)
Figure 76. Bioline Revenue Growth Rate in Competent Cells Business (2019-2024)
Figure 77. Delphi Genetics Revenue Growth Rate in Competent Cells Business (2019-2024)
Figure 78. IBA GmBH Revenue Growth Rate in Competent Cells Business (2019-2024)
Figure 79. Cell Applications Revenue Growth Rate in Competent Cells Business (2019-2024)
Figure 80. BioDynamics Laboratory Revenue Growth Rate in Competent Cells Business (2019-2024)
Figure 81. Scarab Genomics Revenue Growth Rate in Competent Cells Business (2019-2024)
Figure 82. GCC Biotech Revenue Growth Rate in Competent Cells Business (2019-2024)
Figure 83. SMOBIO Technology Revenue Growth Rate in Competent Cells Business (2019-2024)
Figure 84. Edge BioSystems Revenue Growth Rate in Competent Cells Business (2019-2024)
Figure 85. Bottom-up and Top-down Approaches for This Report
Figure 86. Data Triangulation
Figure 87. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which region is expected to have the highest market share?
For each regional market, the report conducted in-depth comparative analysis from multiple dimensions such as market size, 9.5% compound annual growth rate, market demand, industrial structure, policy environment, and the layout of major enterprises. It systematically summarized the market characteristics and competitive environment of different regions. At the same time, it also focused on analyzing the demand structure, market growth drivers, and investment environment of each region, providing valuable references for enterprises to identify key regional markets, formulate global market layouts and sales strategies.
What was the global market size of Competent Cells in 2024?
Which companies rank high in the global Competent Cells market?
What is the annual compound growth rate of the global Competent Cells market size from 2024 to 2030?
What was the global market size of Competent Cells in 2030?
Related Reports
Global Competent Cells Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Competent Cells market size was US$ 2585 million in 2025 and is forecast to reach a readjusted size of US$ 4837 million by 2032 with a CAGR of 9.5% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 111
USD 4250.00
(Single User License)
Global Competent Cells Market Research Report 2026
The global Competent Cells market was valued at US$ 2585 million in 2025 and is anticipated to reach US$ 4837 million by 2032, at a CAGR of 9.5% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 149
USD 2900.00
(Single User License)
Competent Cells - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Competent Cells was estimated to be worth US$ 2585 million in 2025 and is projected to reach US$ 4837 million, growing at a CAGR of 9.5% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 144
USD 3950.00
(Single User License)
Global Competent Cells Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Competent Cells market is projected to grow from US$ 2382 million in 2024 to US$ 4456 million by 2031, at a CAGR of 9.5% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-09-11
Pages: 173
USD 4900.00
(Single User License)
Global Competent Cells Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Competent Cells was estimated to be worth US$ 2382 million and is forecast to reach approximately US$ 4456 million by 2031 with a CAGR of 9.5% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 166
USD 5900.00
(Single User License)
Global Competent Cells Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Competent Cells market size was US$ 2382 million in 2024 and is forecast to a readjusted size of US$ 4456 million by 2031 with a CAGR of 9.5% during the forecast period 2025-2031.
Published Date: 2025-03-19
Pages: 119
USD 4250.00
(Single User License)
Competent Cells- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Competent Cells was estimated to be worth US$ 2382 million in 2024 and is forecast to a readjusted size of US$ 4456 million by 2031 with a CAGR of 9.5% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 155
USD 3950.00
(Single User License)
Global Competent Cells Market Research Report 2025
The global market for Competent Cells was valued at US$ 2382 million in the year 2024 and is projected to reach a revised size of US$ 4456 million by 2031, growing at a CAGR of 9.5% during the forecast period.
Published Date: 2025-01-16
Pages: 110
USD 2900.00
(Single User License)
Global Competent Cells Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Competent cells are bacteria which can accept extra-chromosomal DNA or plasmids. Cells can be made competent in several ways. One such way is to "shock" it, which involves cooling the bacteria in a Calcium Chloride bath at 0 degrees Celsius, then quickly heating it to around 47 degrees Celsius for approximately 90 seconds (too long will denature the cell membrane, killing the bacteria). The calcium chloride ions neutralize the repulsion between the negatively charged phospholipid heads of the cell membrane and the negatively charged phosphate groups on the DNA. The quick heat shock creates a thermal gradient which, in turn, creates a draft leading into the cell, allowing extra-chromosomal DNA (such as plasmids) to enter the cell, allowing the bacterium to be genetically modifed.
Published Date: 2024-04-17
Pages: 189
USD 5600.00
(Single User License)
Global Competent Cells Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Competent cells are bacteria which can accept extra-chromosomal DNA or plasmids. Cells can be made competent in several ways. One such way is to "shock" it, which involves cooling the bacteria in a Calcium Chloride bath at 0 degrees Celsius, then quickly heating it to around 47 degrees Celsius for approximately 90 seconds (too long will denature the cell membrane, killing the bacteria). The calcium chloride ions neutralize the repulsion between the negatively charged phospholipid heads of the cell membrane and the negatively charged phosphate groups on the DNA. The quick heat shock creates a thermal gradient which, in turn, creates a draft leading into the cell, allowing extra-chromosomal DNA (such as plasmids) to enter the cell, allowing the bacterium to be genetically modifed.
Published Date: 2024-04-16
Pages: 190
USD 5900.00
(Single User License)
Global Competent Cells Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Competent Cells market size was US$ 2585 million in 2025 and is forecast to reach a readjusted size of US$ 4837 million by 2032 with a CAGR of 9.5% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 111
USD 4250.00 (Single User License)Global Competent Cells Market Research Report 2026
The global Competent Cells market was valued at US$ 2585 million in 2025 and is anticipated to reach US$ 4837 million by 2032, at a CAGR of 9.5% from 2026 to 2032.
Published: 2026-01-04
Pages: 149
USD 2900.00 (Single User License)Competent Cells - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Competent Cells was estimated to be worth US$ 2585 million in 2025 and is projected to reach US$ 4837 million, growing at a CAGR of 9.5% from 2026 to 2032.
Published: 2026-01-04
Pages: 144
USD 3950.00 (Single User License)Global Competent Cells Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Competent Cells market is projected to grow from US$ 2382 million in 2024 to US$ 4456 million by 2031, at a CAGR of 9.5% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-09-11
Pages: 173
USD 4900.00 (Single User License)Global Competent Cells Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Competent Cells was estimated to be worth US$ 2382 million and is forecast to reach approximately US$ 4456 million by 2031 with a CAGR of 9.5% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 166
USD 5900.00 (Single User License)Global Competent Cells Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Competent Cells market size was US$ 2382 million in 2024 and is forecast to a readjusted size of US$ 4456 million by 2031 with a CAGR of 9.5% during the forecast period 2025-2031.
Published: 2025-03-19
Pages: 119
USD 4250.00 (Single User License)Competent Cells- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Competent Cells was estimated to be worth US$ 2382 million in 2024 and is forecast to a readjusted size of US$ 4456 million by 2031 with a CAGR of 9.5% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 155
USD 3950.00 (Single User License)Global Competent Cells Market Research Report 2025
The global market for Competent Cells was valued at US$ 2382 million in the year 2024 and is projected to reach a revised size of US$ 4456 million by 2031, growing at a CAGR of 9.5% during the forecast period.
Published: 2025-01-16
Pages: 110
USD 2900.00 (Single User License)Global Competent Cells Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Competent cells are bacteria which can accept extra-chromosomal DNA or plasmids. Cells can be made competent in several ways. One such way is to "shock" it, which involves cooling the bacteria in a Calcium Chloride bath at 0 degrees Celsius, then quickly heating it to around 47 degrees Celsius for approximately 90 seconds (too long will denature the cell membrane, killing the bacteria). The calcium chloride ions neutralize the repulsion between the negatively charged phospholipid heads of the cell membrane and the negatively charged phosphate groups on the DNA. The quick heat shock creates a thermal gradient which, in turn, creates a draft leading into the cell, allowing extra-chromosomal DNA (such as plasmids) to enter the cell, allowing the bacterium to be genetically modifed.
Published: 2024-04-17
Pages: 189
USD 5600.00 (Single User License)Global Competent Cells Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Competent cells are bacteria which can accept extra-chromosomal DNA or plasmids. Cells can be made competent in several ways. One such way is to "shock" it, which involves cooling the bacteria in a Calcium Chloride bath at 0 degrees Celsius, then quickly heating it to around 47 degrees Celsius for approximately 90 seconds (too long will denature the cell membrane, killing the bacteria). The calcium chloride ions neutralize the repulsion between the negatively charged phospholipid heads of the cell membrane and the negatively charged phosphate groups on the DNA. The quick heat shock creates a thermal gradient which, in turn, creates a draft leading into the cell, allowing extra-chromosomal DNA (such as plasmids) to enter the cell, allowing the bacterium to be genetically modifed.
Published: 2024-04-16
Pages: 190
USD 5900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now